24 Jun 2021 eTheRNA en VUB breiden strategische samenwerking uit om mRNAproducten van de tweede generatie te ontwerpen met TetraMix Member news
22 Jun 2021 Janssen Pharmaceutica NV plant eerste Europese productiecentrum voor celtherapie in België Member news
22 Jun 2021 Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy Member news
17 Jun 2021 Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols Member news
17 Jun 2021 argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us